this post was submitted on 28 Sep 2025

21 points (100.0% liked)

Futurology

3314 readers

26 users here now

founded 2 years ago

MODERATORS

AwesomeLowlander

21

Lenacapavir, a twice-yearly injection that offers near-total protection against HIV, will now be available for $40 per patient a year, in 120 low- and middle-income countries. (self.futurology)

submitted 1 day ago by Lugh to c/futurology

5 comments fedilink hide all child comments

Lenacapavir will still cost $28,000 a year in the US.

Patents should allow the first generic versions of Semaglutide (Ozempic) to appear next year. Again in low income countries, not developed nations.

Are we going to see a future trend of poorer countries bettering developed countries in health outcomes?

Philanthropies Strike a Promising Deal to Turn Back H.I.V.

you are viewing a single comment's thread
view the rest of the comments

[–] null_dot@lemmy.dbzer0.com 4 points 1 day ago

In Australia this is going to be available under our Pharmaceutical Benefits Scheme soon. Essentially the federal government would / will be the only Australian buyer from the manufacturer.

The govt will pay the commercial price, but they have vastly better bargaining power. Then patients receive it for free.

Existing anti-retro-virals were also expensive when first released. $2,000 per patient / month wouldn't be extreme.